U.S. Central Venous Catheter Market Growth Analysis By Manufacturers, Regions, Types And Application Forecast 2018–2026
Central venous catheter is a thin, flexible tube (catheter) that is placed into the large vein above the heart, usually through a vein in the neck, chest, or arm. It’s also called the central venous line or central line. Central venous catheters are used to administer chemotherapy drugs, intravenous (IV) fluids, antibiotics, blood and platelet transfusions, parenteral nutrition, etc. The peripherally inserted catheter is the commonly used central venous catheter due to several advantages such as easy to insert and remove, easy to repair. Central venous catheters need special care. They may require regular cleaning or dressing employing sterile techniques. Central venous access is a commonly performed procedure with about 8% of hospitalized patients needing central venous access during the course of their hospital stay. More than five million central venous catheters are inserted in the U.S. each year.
Rising adoption and increasing demand for antimicrobial-coated catheters, rising number of chronic diseases such as cancer, end-stage renal disease and others, increasing geriatric population, and rising usage of tip location devices are anticipatead to drive the global U.S. central venous catheter market. Other factors such as favorable insurance and reimbursement policies, technological innovation, and early adoption of diagnostic procedures are likely to fuel the overall U.S. central venous catheter market. According to the U.S.Department of Health and Human Services, national expenditures for cancer treatment in the U.S. was nearly US$ 825.9 million in 2018 and is estimated to reach US$ 1,332.2 Million by 2026. On the other hand, the risks associated with catheters and pricing pressure are projected to hinder the expansion of the global U.S. central venous catheter market.
The Central Venous Catheters are used for monitoring the hemodynamic variables and measuring the central venous pressure. The patients who are suffering from cancer, various chronic disorders, and gastrointestinal diseases will require high immune nutrition which is provided through catheters and thus increasing in the demand. The rapid growth in the number of hospitalizations coupled with the high acquisition of the CVCs that augments the growth of the U.S. central venous catheter market.
The important growth drivers for the Central Venous Catheters Market is the increasing number of cardiovascular and cancer patients, aging population, and people who are suffering from many different chronic disorders are the prior factors that are driving the U.S. central venous catheter market.
Comments
Post a Comment